Correlation Between the Expression of VEGF and N-ras/pERK1/2 Signal Pathway and Its Clinical Significance in Acute Myeloid Leukemia

Feng Jin

2005-01-01

Abstract:OBJECTIVE: To investigate the expression of VEGF, N-Ras and pERK1/2,in order to clarify the relationship between the expression of VEGF and N-Ras/ERK signal pathway in the development of human acute myeloid leukemia(AML). METHODS: The expression level of VEGF, N-Ras and pERK1/2 was checked in the samples of bone marrow mononuclear cells from 46 diagnosed AML patients using immunohistochemistry method, and mutation analysis at N-ras codon 12 was finished using the method of PCR/RFLP, PCR/SSCP and DNA sequencing analysis. RESULTS: The expression of VEGF, N-Ras and pERK1/2 were significantly higher in 28 cases of newly diagnosed AML patients [(52.1±0.31)%,(59.8±0.32)%,(41.9±0.38)%,respectively] than that of 20 cases of normal control [(20.5±0.16)%,(20.9±0.12)%,(14.1±0.14)%;P=0.034,P=0.008,P=0.005, respectively],and that of 18 cases of complete remission AML(CR AML)[(18.6±0.18)%,(28.2±0.27)%,(15.1±0.19)%;P=0.029, P=0.018 ,P=0.008,respectively]; meanwhile, there was no significant different for the expression level of VEGF, N-Ras and pERK1/2 between the group of CR AML and normal control (P0.05, P=0.411, P=0.343). There was no mutation at N-ras codon 12 in all of patients suffering from AML. Close relationship was founded between the expression of VEGF, N-Ras and pERK1/2 (VEGF N-Ras:r=0.510,P=0.003;VEGF pERK1/2:r=0.513,P=0.003;VEGF pERK1/2:r=0.464,P=0.009). CONCLUSIONS: VEGF, cooperating with N-Ras/ERK signal pathway play some roles, and N-Ras/ERK signal pathway was seldom affected, if not all, by N-ras mutation, in the development of human acute myeloid leukemia.